Publicacións en colaboración con investigadores/as de University of Manchester (15)

2023

  1. Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data from the International GOSAFE Study

    Journal of Clinical Oncology, Vol. 41, Núm. 34, pp. 5247-5262

  2. The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

    Therapeutic Advances in Medical Oncology, Vol. 15

2022

  1. Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study

    Journal of the National Cancer Institute, Vol. 114, Núm. 7, pp. 969-978

2020

  1. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

    Clinical and Translational Allergy

  2. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® App

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 7, pp. 1672-1688

  3. Differentiation between athlete's heart and dilated cardiomyopathy in athletic individuals

    Heart

  4. GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients

    Journal of Geriatric Oncology, Vol. 11, Núm. 2, pp. 244-255

  5. Response to eLetter: Fascinating helpful article, but how typical were the patients with DCM and what does this tell us?

    Heart

2019

  1. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 3, pp. 864-879

2018

  1. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

    Clinical and Translational Allergy, Vol. 8, Núm. 1

2011

  1. Interleukin-1 beta gene polymorphism in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

2010

  1. Interleukin-1 receptor antagonist gene polymorphism in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

2009

  1. Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

2007

  1. Endothelial nitric oxide synthase polymorphisms in biopsy-proven erythema nodosum from a defined population

    Clinical and Experimental Rheumatology, Vol. 25, Núm. 4, pp. 624-626

2004

  1. E-selectin polymorphism in erythema nodosum secondary to sarcoidosis

    Clinical and Experimental Rheumatology, Vol. 22, Núm. 2, pp. 230-232